Literature DB >> 27086122

Development of a peptide-based inducer of nuclear receptors degradation.

Yosuke Demizu1, Nobumichi Ohoka2, Takaya Nagakubo2, Hiroko Yamashita2, Takashi Misawa2, Keiichiro Okuhira3, Mikihiko Naito2, Masaaki Kurihara4.   

Abstract

A peptide-based protein knockdown system for inducing nuclear receptors degradation via the ubiquitin-proteasome system was developed. Specifically, the designed molecules were composed of two biologically active scaffolds: a peptide that binds to the estrogen receptor α (ERα) surface and an MV1 molecule that binds to cellular inhibitors of apoptosis proteins (IAP: cIAP1/cIAP2/XIAP) to induce ubiquitylation of the ERα. The hybrid peptides induced IAP-mediated ubiquitylation followed by proteasomal degradation of the ERα. Those peptides were also applicable for inducing androgen receptor (AR) degradation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Helical peptide; Nuclear receptors; Protein knockdown; Protein–protein interaction

Mesh:

Substances:

Year:  2016        PMID: 27086122     DOI: 10.1016/j.bmcl.2016.04.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges.

Authors:  Chao Wang; Yujing Zhang; Tingting Zhang; Lingyu Shi; Zhongmin Geng; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 2.  Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents.

Authors:  Chao Wang; Yujing Zhang; Lingyu Shi; Shanbo Yang; Jing Chang; Yingjie Zhong; Qian Li; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

3.  Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation.

Authors:  Nobumichi Ohoka; Yoko Morita; Katsunori Nagai; Kenichiro Shimokawa; Osamu Ujikawa; Ikuo Fujimori; Masahiro Ito; Youji Hayase; Keiichiro Okuhira; Norihito Shibata; Takayuki Hattori; Tomoya Sameshima; Osamu Sano; Ryokichi Koyama; Yasuhiro Imaeda; Hiroshi Nara; Nobuo Cho; Mikihiko Naito
Journal:  J Biol Chem       Date:  2018-03-15       Impact factor: 5.157

Review 4.  Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs.

Authors:  Minoru Ishikawa; Shusuke Tomoshige; Yosuke Demizu; Mikihiko Naito
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-21

5.  TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals.

Authors:  Lili Liang; Chuantao Cheng; Guanglei Hu; Xuening Wang; Jing Liu; Zhu Yan; Weihui Zeng; Yumin Xia
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.